Pezzola S, Antonini G, Geroni C, Beria I, Colombo M, Broggini M, Mongelli N, Leboffe L, MacArthur R, Mozzi AF, Federici G, Caccuri AM: Role of glutathione transferases in the mechanism of brostallicin activation
Understanding these differences helps set appropriate expectations for efficacy, side effects, and overall treatment experience
Reports from other countries have indicated that some individuals have experienced genuine relief, while others have suffered severe adverse effects, ranging from rapid heart rate and elevated liver enzymes to kidney issues
Your best choice depends on how you manage routine, side effects, costs, and whether you can combine medication with good habits that preserve muscle and hydration
Published in the New England Journal of Medicine, this trial enrolled 2,539 adults with obesity or overweight (with at least one weight-related comorbidity) who did not have diabetes
In May 2026, Novo Nordisk is set to showcase its expansive cardiometabolic and diabetes pipeline at the American Diabetes Associations (ADA) 2026 Scientific Sessions, presenting a total of 40 abstracts